Editorial Board

 

Editor-in-Chief

Tsuyoshi Miyakawa, Fujita Health University, Aichi, Japan


Section Editors

Alcohol and Addiction Studies
Kazutaka Ikeda, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Clinical Neuropsychopharmacology
Hikaru Hori, Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Clinical/Translational Neuropsychopharmacology
Tomiki Sumiyoshi, Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan

Basic Neuropsychopharmacology and Neuroscience Research
Masabumi Minami, Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan


Editorial Board

Ciobica Alin, Universitatea Alexandru Ioan Cuza, Lasi, Romania

Bernhard T Baune, University of Münster, Münster, Germany

Lih-Chu Chiou, National Taiwan University, Taipei, Taiwan

Brian Dean, University of Melbourne, Melbourne, Australia

Chiara Fabbri, University of Bologna, Bologna, Italy

Tomoyuki Furuyashiki, Kobe University, Hyogo, Japan

Takatoshi Hikida, Osaka University, Osaka, Japan

Noboru Hiroi, University of Texas Health Science Center, Texas, United States

Yoshinori Horie, KI Clinic, Medical Corporations KEIYOUKAI, Tokyo, Japan

Jun-ichi Iga, Department of Neuropsychiatry, Ehime University Graduate School of Medicine, Ehime, Japan

Masaaki Iwata, Faculty of Medicine, Tottori University, Tottori, Japan

Shinya Kasai, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Mitsuru Kimura, National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan

Katsunori Kobayashi, First Department of Physiology, Wakayama Medical University, Wakayama, Japan

Hisatsugu Koshimizu, Fujita Health University, Aichi, Japan

Mitsuyuki Matsumoto, Arialys Therapeutics, Inc., La Jolla, USA

Robert Mccullumsmith, University of Toledo, Toledo, USA

Hirofumi Morishita, Icahn School of Medicine at Mount Sinai, New York, United States

Takayuki Nakagawa, Department of Clinical Pharmacology and Pharmacotherapy, Wakayama Medical University, Wakayama, Japan

Kazuyuki Nakagome, National Center of Neurology and Psychiatry, Tokyo, Japan

Shinichiro Nakajima, Keio University, Tokyo, Japan

Atsumi Nitta, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

Kazutaka Ohi, Kanazawa Medical University, Ishikawa, Japan

Nills Opel, University of Münster, Münster, Germany

Hitoshi Sakurai, Department of Neuropsychiatry, Kyorin University Faculty of Medicine, Tokyo, Japan

Junji Saruwatari, Division of Pharmacology & Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

Winston Shen, Taipei Medical University, Taipei, Taiwan

Edoardo Spina, University of Messina, Messina, Italy

Hiroko Sugawara, Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Yoshiteru Takekita, Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan

Sayaka Takemoto, Nagoya University, Aichi, Japan

Makoto Taniguchi, Medical University of South Carolina, Charleston, USA

Andi J Tanra, Hasanuddin University, Makassar, Indonesia

Miho Terunuma, Niigata University, Niigata, Japan

Hiroyuki Uchida, Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Wataru Ukai, Sapporo Medical University, Hokkaido, Japan

Norio Yasui-Furukori, Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan

Reiji Yoshimura, Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan